PHILADELPHIA , Nov. 10, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against V.F. Corporation (NYSE: VFC) ("VFC" or the "Company") on behalf of investors who purchased or acquired VFC shares during the period from October 30, 2023 through May 20, 2025 (the "Class Period").

NEW YORK , Nov. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP) resulting from allegations that Zions Bancorporation may have issued materially misleading business information to the investing public.

Expedia's bookings growth accelerated based on strength in its business-to-business activities, and management raised its outlook. Despite reporting better results, FMC's share price was weak. Pinnacle Financial lagged after announcing an all-stock acquisition of a rival company.

LOS ANGELES, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 2, 2026 to deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX) securities between June 20, 2025 and September 24, 2025, inclusive (the “Class Period”).

WESTPORT, Conn.--(BUSINESS WIRE)--UBS Global Wealth Management US today announced that Daniel Holzer has joined the firm as a Financial Advisor. Dan joins the UBS Westport, Connecticut office, which is managed by Market Director Jim Miller and is part of the Greater New York Market, led by Market Executive Mara Glassel. “On behalf of UBS, we're excited to welcome Dan to the firm,” said Jim Miller, Market Director at UBS Wealth Management. “His industry experience and dedication to his clients w.

Syndax Pharmaceuticals, Inc. ( SNDX ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Michael Metzger - CEO & Director Nicholas Botwood - Head of Research & Development and Chief Medical Officer Steven Closter - Chief Commercial Officer Conference Call Participants Xiaochuan Dai - UBS Investment Bank, Research Division Presentation Xiaochuan Dai UBS Investment Bank, Research Division Okay. Well, thanks for joining.

ProFrac Holding Corp. ( ACDC ) Q3 2025 Earnings Call November 10, 2025 11:00 AM EST Company Participants Michael Messina Matthew Wilks - Executive Chairman & President Ladd Wilks - Chief Executive Officer Austin Harbour - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel, Nicolaus & Company, Incorporated, Research Division John Daniel - Daniel Energy Partners, LLC Daniel Kutz - Morgan Stanley, Research Division Donald Crist - Johnson Rice & Company, L.L.C., Research Division Presentation Operator Greetings, and welcome to the ProFrac Third Quarter 2025 Earnings Call.

Sonida Senior Living, Inc. ( SNDA ) Q3 2025 Earnings Call November 10, 2025 11:00 AM EST Company Participants Jason Finkelstein Brandon Ribar - President, CEO & Director Kevin Detz - Executive VP & CFO Conference Call Participants Derrick Metzler - Morgan Stanley, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Presentation Operator Thank you for standing by. At this time, I would like to welcome everyone to the Sonida Senior Living Third Quarter Earnings Call.

ARS Pharmaceuticals, Inc. ( SPRY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Justin Chakma - Chief Business Officer Richard Lowenthal - Co-Founder, President, CEO & Director Eric Karas - Chief Commercial Officer Kathleen Scott - Chief Financial Officer Conference Call Participants Lachlan Hanbury-Brown - William Blair & Company L.L.C., Research Division Joshua Schimmer - Cantor Fitzgerald & Co., Research Division Roanna Clarissa Ruiz - Leerink Partners LLC, Research Division Andreas Argyrides - Oppenheimer & Co. Inc., Research Division Kevin Holder - ROTH Capital Partners, LLC, Research Division Presentation Operator Good morning and welcome to …

Barrick Mining Corporation ( ABX:CA ) Q3 2025 Earnings Call November 10, 2025 11:00 AM EST Company Participants Cleveland Rueckert Mark Hill - Group COO, Interim President & CEO Graham Shuttleworth - Senior EVP & CFO Henri Gonin - Managing Director of Nevada Gold Mines Conference Call Participants Fahad Tariq - Jefferies LLC, Research Division Matthew Murphy - BMO Capital Markets Equity Research Daniel Major - UBS Investment Bank, Research Division Tanya Jakusconek - Scotiabank Global Banking and Markets, Research Division Anita Soni - CIBC Capital Markets, Research Division John Tumazos - John Tumazos Very Independent Research, LLC Presentation Operator …

United Therapeutics Corporation ( UTHR ) UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM EST Company Participants Patrick Poisson - Executive VP of Technical Operations Conference Call Participants Ashwani Verma - UBS Investment Bank, Research Division Terence Flynn - Morgan Stanley, Research Division Presentation Ashwani Verma UBS Investment Bank, Research Division Good day, everybody. Welcome to UBS Healthcare Conference.

S&P Global has underperformed the S&P 500 over the past five years, hurting its reputation as a long-term compounder. SPGI's valuation multiple expanded while growth and business quality declined, raising questions about a premium valuation. Recent Q3 results beat expectations, and 2025 guidance was raised, but the core investment thesis remains unchanged: modest growth and stable margins.

Behind the buying is news that the Senate is pushing forward legislation that would end the U.S. government shutdown.

History is on the side of the financial sector with the prospect of additional rate cuts to come. This could provide the perfect investment opportunity for an active ETF like the Fidelity Disruptive Finance ETF (FDFF).

GREEN BAY, Wis.--(BUSINESS WIRE)--Schneider National, Inc. (NYSE: SNDR), a premier multimodal provider of transportation, intermodal and logistics services, is introducing Schneider Fast Track, a premium solution designed for shippers with time-sensitive and high-service freight needs. Fast Track combines Schneider's extensive asset-based truckload and intermodal capabilities with strategic rail partnerships to create a network of some of the fastest, most consistent intermodal lanes in the ind.

The JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) stands out as a high-quality covered call ETF with a robust 10% yield at current prices. JEPQ's total returns have been compelling, and its price upside is less capped compared to other covered call ETFs, making it attractive for investors. Rising market volatility could further benefit JEPQ, as higher option premiums would likely boost dividends for shareholders.

ARS Pharmaceuticals, Inc. delivered strong Q3 Neffy sales, doubling sequentially, but remains unprofitable with high SG&A expenses and no 2026 guidance. SPRY faces competitive threats from generics and upcoming alternatives, but patent litigation could delay generic Neffy entry until 2039. Neffy's needle-free, lower-cost profile is driving adoption, with growing prescriber base and international launches, but long-term profitability remains uncertain.

Oil traders are not ready for big moves amid lack of strong catalysts.

New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Alphabet's self-driving car unit Waymo appointed a new CFO Monday. The company tapped Google finance executive Steve Fieler.